Product Images Rosuvastatin Calcium

This text appears to be showing statistical values related to a study or experiment. It includes data on different groups (HR0.56 with a confidence interval, p-value), cumulative incidence percentages, and the number at risk in each group over time. The text provides relevant information for analyzing the outcomes of the study.*

This text presents a comparison between Rosuvastatin 20 mg and Placebo 20 mg in a study with 8901 participants. It shows the number of events for various endpoints such as the primary endpoint (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, unstable angina, and arterial revascularization. The Hazard Ratios (HR) and their corresponding confidence intervals are provided, along with the p-values. The data suggests that Rosuvastatin 20 mg reduced the risk of primary endpoint events, cardiovascular death, nonfatal stroke, nonfatal MI, unstable angina, and arterial revascularization compared to Placebo 20 mg.*

This is a description of Rosuvastatin 5mg tablets produced by Glenmark Pharmaceuticals Inc. The tablets are pink colored and circular, with a "G" on one side and "C" on the other. Each tablet contains rosuvastatin calcium, USP equivalent to 5 mg rosuvastatin. The tablets are film-coated and come in a pack of 30. The medication should be stored at 20°-25°C (68°-77°F) and kept out of reach of children. The tablets are manufactured in India and distributed by Proficient Rx LP in the USA.*

This text does not provide enough information for a useful description.*